Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

MegaChem Ltd
SGX:5DS

Watchlist Manager
MegaChem Ltd Logo
MegaChem Ltd
SGX:5DS
Watchlist
Price: 0.42 SGD Market Closed
Market Cap: S$56m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-11%
5Y
+23%
10Y
+32%
Liabilities
+
3Y
-20%
5Y
+34%
10Y
+24%
Equity
+
3Y
-1%
5Y
+15%
10Y
+40%

Balance Sheet Decomposition
MegaChem Ltd

Balance Sheet
MegaChem Ltd

Rotate your device to view
Balance Sheet
Currency: SGD
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
2
4
7
6
5
3
3
5
5
6
7
8
9
9
11
12
9
12
15
16
12
12
14
16
Cash
0
0
0
6
5
3
3
5
5
6
7
0
9
9
11
12
9
12
15
16
12
12
14
16
Cash Equivalents
2
4
7
0
0
0
0
0
0
0
0
8
0
0
0
0
0
0
0
0
0
0
0
0
Short-Term Investments
0
0
0
2
2
1
2
2
1
1
1
0
0
0
0
0
1
0
0
0
1
0
0
0
Total Receivables
14
13
15
16
13
15
19
19
21
23
22
24
26
30
26
24
28
24
23
24
31
28
24
23
Accounts Receivables
14
13
15
15
13
15
18
19
21
23
21
23
26
30
26
24
28
24
23
24
31
28
24
23
Other Receivables
0
0
0
1
1
1
1
1
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
11
11
11
12
13
14
14
15
14
20
23
21
21
23
21
20
24
26
25
24
36
49
34
32
Other Current Assets
1
0
0
1
1
2
2
1
2
1
1
1
1
0
2
2
2
2
2
3
5
2
2
3
Total Current Assets
28
29
33
38
33
36
40
42
44
51
54
54
57
62
60
59
63
65
66
68
84
91
73
74
PP&E Net
7
6
6
5
5
4
3
4
3
3
9
13
12
14
12
11
11
11
13
15
18
18
17
19
PP&E Gross
7
6
6
5
5
4
3
4
3
3
9
13
12
14
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
5
5
6
6
7
7
8
8
8
9
9
10
11
0
0
0
0
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Goodwill
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
1
1
1
1
2
3
3
3
4
5
6
6
7
5
3
6
6
7
8
8
8
10
11
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
1
1
Other Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
35
N/A
36
+3%
41
+14%
45
+9%
40
-10%
42
+5%
46
+9%
48
+4%
51
+6%
59
+16%
68
+15%
72
+7%
75
+3%
83
+12%
78
-7%
73
-6%
80
+9%
82
+2%
86
+5%
91
+6%
111
+21%
117
+6%
100
-14%
105
+4%
Liabilities
Accounts Payable
5
4
5
4
3
5
5
4
4
5
6
8
8
0
14
13
16
12
12
14
18
15
15
15
Accrued Liabilities
0
0
0
1
1
1
3
2
3
4
4
3
4
0
0
0
0
0
0
0
0
0
0
0
Short-Term Debt
12
11
9
10
5
5
6
8
7
10
10
11
14
18
15
12
15
18
17
17
28
35
28
25
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
1
4
1
0
0
0
0
1
0
0
0
0
0
Other Current Liabilities
1
1
1
1
1
1
1
1
3
2
2
3
3
5
0
0
0
0
0
0
1
1
0
0
Total Current Liabilities
18
16
15
16
10
12
14
15
16
21
22
26
32
36
29
26
31
30
30
31
47
52
44
41
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
5
4
0
3
4
3
2
1
3
5
4
3
3
3
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Minority Interest
0
1
1
1
1
1
1
1
1
2
2
2
2
3
3
3
3
3
3
3
3
3
3
2
Total Liabilities
19
N/A
17
-7%
16
-7%
18
+9%
12
-34%
13
+11%
16
+20%
17
+7%
17
+3%
23
+31%
29
+26%
32
+13%
34
+6%
41
+20%
36
-14%
31
-12%
35
+13%
35
-2%
37
+6%
39
+6%
54
+38%
58
+9%
50
-14%
46
-9%
Equity
Common Stock
11
11
13
13
13
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
Retained Earnings
5
7
9
11
13
13
14
15
17
20
23
26
27
29
26
26
29
31
34
37
41
43
34
43
Additional Paid In Capital
0
0
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
0
2
3
0
0
0
0
0
0
0
0
0
0
0
Total Equity
16
N/A
18
+14%
25
+34%
27
+10%
29
+6%
29
+2%
30
+4%
31
+3%
33
+7%
36
+8%
39
+8%
40
+2%
40
+1%
42
+4%
42
+1%
42
0%
45
+6%
47
+6%
50
+5%
52
+6%
57
+9%
59
+2%
50
-15%
59
+17%
Total Liabilities & Equity
35
N/A
36
+3%
41
+14%
45
+10%
40
-10%
42
+5%
46
+9%
48
+4%
51
+6%
59
+16%
68
+15%
72
+7%
75
+3%
83
+12%
78
-7%
73
-6%
80
+9%
82
+2%
86
+5%
91
+6%
111
+21%
117
+6%
100
-14%
105
+4%
Shares Outstanding
Common Shares Outstanding
108
11
133
133
133
133
133
133
133
133
133
133
133
133
133
133
133
133
133
133
133
133
133
133

See Also

Summary
5DS intrinsic value, competitors valuation, and company profile.
DCF Valuation
5DS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
5DS stock valuation using valuation multiples.
Wall Street Estimates
5DS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
5DS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.